The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Radiation Research"
DOI: 10.1093/jrr/rraa074
Abstract: Abstract The feasibility and efficacy of hypofractionated salvage radiotherapy (HS-RT) for prostate cancer (PC) with biochemical recurrence (BR) after prostatectomy, and the usefulness of prostate-specific antigen (PSA) kinetics as a predictor of BR, were evaluated… read more here.
Keywords: prostate; salvage radiotherapy; prostate cancer; hypofractionated salvage ... See more keywords
Comparison of multiparametric MRI to PSA kinetics as an indication of prostate cancer progression in men on active surveillance.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.6_suppl.59
Abstract: 59Background: Pathologic progression is identified in > 25% of prostate cancer (CaP) patients on active surveillance (AS). Yet, identifying patients at risk for progression is limited to PSA based biomarkers with variable utility. Multiparametric MRI… read more here.
Keywords: active surveillance; prostate cancer; mri; progression ... See more keywords
Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14030815
Abstract: Simple Summary In prostate cancer patients with rising prostate-specific antigens (PSAs) after primary local therapy, and at high risk of metastatic disease based on a high Gleason score or ISUP grades 4–5 and/or short PSA… read more here.
Keywords: therapy; longitudinal psa; psa; prognostic value ... See more keywords
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14092219
Abstract: Simple Summary Prostate cancer is a very common disease in men. Nowadays several life-prolonging therapies are available, also efficient in the metastatic setting. However, it is important to choose the best approach for each patient,… read more here.
Keywords: dna ctdna; ctdna; treated abiraterone; gain ... See more keywords